Trump is right: Abusive patents are the culprit behind high drug prices, but his plan doesn’t solve anything
Collective Efforts By Civil Society Groups Bar The Way To Hepatitis C Patents
Tahir Amin: Increasing Access to Affordable HIV Drugs Through Patent Opposition
A Supreme Court victory for lowering drug prices
Tahir Amin: Transparency in Drug Pricing
Tahir Amin: Pay-for-Delay Settlements and Patient Access
Tahir Amin: The Role of Advocacy Groups in the Patent System
Gilead patent for its Sovaldi hepatitis C drug is rejected in Ukraine
Ready to Leave the Private Sector for Public Service? Read This First.
Another reason to visit Egypt: Europe’s high drug prices